Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT01281020
Eligibility Criteria:
Inclusion Criteria:
* Patient is between 21-80 years old
* Patient has ocular hypertension or open-angle glaucoma Patient receives therapy and is well controlled on fixed or unfixed latanoprost and timolol therapy
* Untreated IOP \>19 mm Hg \<33 mm Hg at baseline (10:00 hour)
* Open normal appearing angles
* Patient had at least a 20% reduction vs untreated baseline on current therapy
* Patient has early or moderate glaucoma (\< 14 decibel; 0.8 or better cupping)
* Distance best corrected Snellen visual acuity greater than 1/10
Exclusion Criteria:
* Contraindication to timolol or prostaglandin therapy
* History of lack of response to any medication (\< 10%)
* Patient does not understand the instructions and will not comply to medications
* Patient can not attend follow up
* Patient is a female of childbearing potential, or lactating mother
* History of trauma, inflammation, surgery, past use of steroids (within 2 months), severe dry eyes and use of contact lenses
* Sign of ocular infection
* A corneal abnormality that may affect IOP measurements
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01281020
Study Brief:
Protocol Section:
NCT01281020